Metabolic flux analysis of cultured hepatocytes exposed to plasma

Authors

  • Christina Chan,

    1. Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, GRB 1401, 55 Fruit Street, Boston, Massachusetts; telephone: 617-371-4882; fax: 617-371-4950
    2. Shriners Hospitals for Children, Boston, Massachusetts
    Search for more papers by this author
  • François Berthiaume,

    1. Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, GRB 1401, 55 Fruit Street, Boston, Massachusetts; telephone: 617-371-4882; fax: 617-371-4950
    2. Shriners Hospitals for Children, Boston, Massachusetts
    Search for more papers by this author
  • Kyongbum Lee,

    1. Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, GRB 1401, 55 Fruit Street, Boston, Massachusetts; telephone: 617-371-4882; fax: 617-371-4950
    2. Shriners Hospitals for Children, Boston, Massachusetts
    Search for more papers by this author
  • Martin L. Yarmush

    Corresponding author
    1. Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, GRB 1401, 55 Fruit Street, Boston, Massachusetts; telephone: 617-371-4882; fax: 617-371-4950
    2. Shriners Hospitals for Children, Boston, Massachusetts
    • Center for Engineering in Medicine/Surgical Services, Massachusetts General Hospital, Harvard Medical School, GRB 1401, 55 Fruit Street, Boston, Massachusetts; telephone: 617-371-4882; fax: 617-371-4950
    Search for more papers by this author

Abstract

Hepatic metabolism can be investigated using metabolic flux analysis (MFA), which provides a comprehensive overview of the intracellular metabolic flux distribution. The characterization of intermediary metabolism in hepatocytes is important for all biotechnological applications involving liver cells, including the development of bioartificial liver (BAL) devices. During BAL operation, hepatocytes are exposed to plasma or blood from the patient, at which time they are prone to accumulate intracellular lipids and exhibit poor liver-specific functions. In a prior study, we found that preconditioning the primary rat hepatocytes in culture medium containing physiological levels of insulin, as opposed to the typical supraphysiological levels found in standard hepatocyte culture media, reduced lipid accumulation during subsequent plasma exposure. Furthermore, supplementing the plasma with amino acids restored hepatospecific functions. In the current study, we used MFA to quantify the changes in intracellular pathway fluxes of primary rat hepatocytes in response to low-insulin preconditioning and amino acid supplementation. We found that culturing hepatocytes in medium containing lower physiological levels of insulin decreased the clearance of glucose and glycerol with a concomitant decrease in glycolysis. These findings are consistent with the general notion that low insulin, especially in the presence of high glucagon levels, downregulates glycolysis in favor of gluconeogenesis in hepatocytes. The MFA model shows that, during subsequent plasma exposure, low-insulin preconditioning upregulated gluconeogenesis, with lactate as the primary precursor in unsupplemented plasma, with a greater contribution from deaminated amino acids in amino acid-supplemented plasma. Concomitantly, low-insulin preconditioning increased fatty acid oxidation, an effect that was further enhanced by amino acid supplementation to the plasma. The increase in fatty acid oxidation reduced intracellular triglyceride accumulation. Overall, these findings are consistent with the notion that the insulin level in medium culture presets the metabolic machinery of hepatocytes such that it directly impacts on their metabolic behavior during subsequent plasma culture. © 2002 Wiley Periodicals, Inc. Biotechnol Bioeng 81: 33–49, 2003.

Ancillary